Genome-wide association study of amidoarone-induced hypothyroidism

27 August 2023 (14:09 - 14:18)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Soren Rand

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail

The clinical implementation of a de-escalation strategy using CYP2C19 genotyping in patients with an acute coronary syndrome: insights from the FORCE-ACS registry

Doctor J. Azzahhafi (Nieuwegein, NL)

Abstract Slides Video

Presentation thumbnail

Arg389Gly beta-1-adrenergic receptor polymorphism determines neutrophil-stunning-associated cardioprotection by metoprolol

Mr A. Clemente Moragon (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort

Doctor E. Magavern (London, GB)

Abstract Slides Video

Presentation thumbnail

Impact of CYP2C19 genotype status on clinical outcomes in patients with symptomatic coronary artery disease, stroke, and peripheral arterial disease

Ms D. Maas (Nijmegen, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Pharmacogenetics: a tool to guide clinical decisions

The Event

Event poster

ESC Congress 2023

27 August 2023 14:09 CET

You may be interested in

Congress Presentation

Potential use of pharmacogenetics in cardiology: genome-wide association studies of amiodarone-induced thyroid disorders

Congress Session

Pharmacogenetics: a tool to guide clinical decisions

Congress Session

Are we ready to use genetic testing for risk stratification of sudden cardiac death?

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources